Browse by regulation1 article · 1 moderate
EU GMP Annex 11
Every DSRV article whose Regulatory Snapshot cites EU GMP Annex 11: the enforcement case behind it, the inspection exposure it created, and what the desk would do about it.
Inspection exposure across the set
- What has FDA cited under EU GMP Annex 11?
- 1 DSRV article cite EU GMP Annex 11. Enforcement cases behind them: Tetrate governance framework, Securing the MCP Supply Chain, published in the first week of June 2026, alongside MCPManager.ai's regulated-industry MCP compliance guide and the Agentic AI Institute's June 2026 enterprise adoption analysis. Inspection exposure across them: 1 moderate.
- What does DSRV recommend for EU GMP Annex 11?
- From the newest article (What Pharma Quality Teams Need to Know About MCP Governance): MCP governance is not a new compliance category; it is Part 11 and Annex 11 applied to a new connection layer, and the validation boundary must cover the agent's tool access before deployment rather than after. DSRV is decision support, not legal advice; verify against the official source each article names.
In brief
Address this risk
Pressure-test your evidence before an inspector reads it
Bring the document that has to hold up under EU GMP Annex 11. DSRV maps the evidence, names the gaps, and routes judgment calls to human review. Controlled intake, no public file upload.
Regulatory intelligence and interpretation, not legal advice. Verify against the official FDA or ICH source each article names.